Bulky lateral carboxylate substituents were introduced at the benzylic position of 2,5-bis[4-(n-perfluoroheptyloctyloxy)benzoyloxy]toluene by esterification of the corresponding benzyl bromide with potassium carboxylates. In spite of the bulky lateral substituents, none of the 2,5-bis[4-(n-perfluoroheptyloctyloxy)benzoyloxy]benzyl carboxylates exhibit a nematic mesophase in addition to, or instead of, the smectic mesophases. All of the crystalline and SmC-SmA transition temperatures and, with the exception of the 9-anthracene carboxylate derivative, all of the isotropization temperatures of the resulting 2,5-bis[4-(n-perfluoroheptyloctyloxy)benzoyloxy]benzyl carboxylates are lower than those of the parent toluene compound. The SmC-SmA transition decreases the most, thereby stabilizing the SmA mesophase. In most cases, the SmC mesophase is destabilized from an enantiotropic to a monotropic mesophase. There is no correlation between any of the transition temperatures and the size of the lateral substituent.
No takes yet. Share an insight, caveat, or question.
Pugh et al. (2001) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: